Perm Federal Scientific Centre, Institute of Technical Chemistry UB RAS, Academician Korolev St. 3, 614013, Perm, Russia.
Institute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentiev Ave., 8, 630090, Novosibirsk, Russia.
Eur J Med Chem. 2024 Oct 5;276:116724. doi: 10.1016/j.ejmech.2024.116724. Epub 2024 Jul 27.
For the first time, a synthetic route for preparing lupane and oleanane derivatives with a hydrogenated furan ring as a cycle A of triterpene scaffold is described. Most of the synthesized compounds, furanoterpenoids and their synthetic intermediates, were non-toxic against the tested cancer and non-cancerous cell lines, and evinced significant inhibitory activity with IC 1.0-9.0 μM in the tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibition test. Lupane derivatives - 1-oxime 7, 1,10-seco-hydroxynitrile 11 and furanoterpenoid 14 - were selected as those expected to be the most promising compounds. The results of molecular modeling evinced the strongest binding of compound 11 to the active site of Tdp1 compared to the reference drug. Simultaneously, only compound 11 at subtoxic concentration (10 μM) produced a synergetic effect on the topotecan activity against HeLa-V cells.
首次描述了一种以氢化呋喃环作为三萜骨架 A 环的制备羽扇烷和齐墩果烷衍生物的合成路线。大多数合成的化合物、呋喃萜类化合物及其合成中间体对测试的癌细胞和非癌细胞系均无毒性,并且在酪氨酰-DNA 磷酸二酯酶 1(Tdp1)抑制试验中具有 1.0-9.0μM 的显著抑制活性。羽扇烷衍生物-1-肟 7、1,10-去氢氰醇 11 和呋喃萜类化合物 14 被选为最有前途的化合物。分子建模的结果表明,与参比药物相比,化合物 11 与 Tdp1 的活性位点结合最强。同时,仅化合物 11 在亚毒性浓度(10μM)下对拓扑替康对 HeLa-V 细胞的活性产生协同作用。